• This Project has received funding from the European Union´s Horizon 2020 research and innovation programme under grant agreement No 945118
RESILIENCE helps you survive cancer with a strong heart
Icon-twitter-x Youtube Facebook Linkedin Instagram

Amsterdam UMC Hospital joins RESILIENCE

It is a great satisfaction for us to announce the incorporation of the Amsterdam UMC Hospital to the RESILIENCE project on November 8th.

Amsterdam UMC is one of the largest academic hospitals in the Netherlands and consists of 2 centers: The Amsterdam UMC located at the AMC (Academic Medical Center) and the Amsterdam UMC, located at the VUMC (Vrije Universiteit Medical Center).

At the Hospital we have met with Marie Jose Kersten, principal investigator; Koen de Heer, coordinator haematologist; Aart J. Nedeveen, image responsible; and the project coordinators, Esra Eyiss and Laurens Grave.

With this Hospital joining the project, RESILIENCE keeps on growing and hopefully patient recruitment will begin in the coming weeks, which will bring our clinical trial closer to more patients so that they may survive cancer with a strong heart.

Back to News

Resilience

Cardiac Magnetic Resonance

  • Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition.

Clinical Trial Synopsis

  • Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic PreConditioning.

For patients

Legals

Follow Us

Twitter Youtube Facebook Linkedin Instagram
  • This Project has received funding from the European Union´s Horizon 2020 research and innovation programme under grant agreement No 945118

RESILIENCE is a CNIC project with a multidisciplinary consortium | All Rights Reserved 2022

Logotipo Resilience

Are you a patient participating in RESILIENCE? Here you will find useful information about the details of your participation, activities specifically designed for you. You will also be able to contact RESILIENCE researchers.

In accordance with the provisions of Regulation (EU) 2016/679 on the protection of personal data of natural persons (GDPR), the personal information you have provided will be incorporated into the data processing systems of the Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) for the purpose of attending your registration application in the restricted area for patients participating in the RESILIENCE study. The legal basis for processing your personal data for this purpose is your explicit consent. Your personal data will not be disclosed to any recipients other than those to whom you authorise or when required by law to do so. You may exercise your rights of access, right to rectification, to object, to erasure, to restriction of processing, data portability and not to be subject to automated individual decision-making. To exercise these rights, as well as to obtain additional information about the processing of your personal data, you can consult the following link Terms and Conditions